Description
Product Overview / 商品概要
Bimatoprost Ophthalmic Solution 0.03% (ルミガン点眼液0.03%)
Generic: Bimatoprost / ビマトプロスト
Therapeutic Category: Prostamide Derivative, Glaucoma/Ocular Hypertension Treatment Agent / プロスタマイド誘導体 緑内障・高眼圧症治療剤
Manufactured by: Senju Pharmaceutical Co., Ltd. / 千寿製薬株式会社
Composition & Specification / 組成・規格
Active Ingredient: Bimatoprost 0.3mg per 1mL / 1mL中 ビマトプロスト 0.3mg
Additives: Sodium hydrogen phosphate hydrate, Citric acid hydrate, Benzalkonium chloride, Isotonicity agents, pH adjusters / リン酸水素ナトリウム水和物、クエン酸水和物、ベンザルコニウム塩化物、等張化剤、pH調節剤
Appearance: Clear, colorless sterile aqueous ophthalmic solution
外観: 無色澄明の無菌水性点眼剤
Indications / 効能効果
EN: Glaucoma, Ocular hypertension
JA: 緑内障、高眼圧症
Dosage and Administration / 用法用量
EN: Instill 1 drop once daily.
JA: 1回1滴、1日1回点眼する。
Contraindications / 禁忌
EN: Patients with a history of hypersensitivity to any component of this product
JA: 本剤の成分に対し過敏症の既往歴のある患者
Regulatory Information / 規制情報
Approval No.: 22100AMX01822
Sales Started: October 2009 / 2009年10月
Classification Code: 871319
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 2.5mL x 5 bottles / 2.5mL×5
Other Available Packages (by special order): Plastic ophthalmic containers: 2.5mL x 5, 2.5mL x 10
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

![Ofloxacin Otic Solution 0.3% [CEO] (Ofloxacin Otic Solution CEO® / オフロキサシン耳科用液0.3%「CEO」)](https://jp-pharma.com/wp-content/uploads/2026/06/OFL-03-OTC_1200x1200-324x324.jpg)


Reviews
There are no reviews yet.